Fuyumi Nishihara

CD4+ T-cell Immunity in the Peripheral Blood Correlates with Response to Anti-PD-1 Therapy

Hiroshi Kagamu, Shigehisa Kitano, Ou Yamaguchi et al. · Cancer Immunology Research · 2019 · 261 citations

Medicine, Immunology, Oncology +17

Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non‐small cell lung cancer patients

Ayako Shiono, Kyoichi Kaira, Atsuto Mouri et al. · Thoracic Cancer · 2019 · 77 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non‐small cell lung cancer: Management of adverse events

Yu Miura, Atsuto Mouri, Kyoichi Kaira et al. · Thoracic Cancer · 2020 · 55 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Radiotherapy is an independent prognostic marker of favorable prognosis in non‐small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab

Ou Yamaguchi, Kyoichi Kaira, Kosuke Hashimoto et al. · Thoracic Cancer · 2019 · 51 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Clinical difference between discontinuation and retreatment with nivolumab after immune-related adverse events in patients with lung cancer

Atsuto Mouri, Kyoichi Kaira, Ou Yamaguchi et al. · Cancer Chemotherapy and Pharmacology · 2019 · 51 citations

Pharmacy, Immunology, Oncology +16